Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Neuropharmacology. 2019 Jun 28;157:107691. doi: 10.1016/j.neuropharm.2019.107691

Table 1. Functional properties of α-Ctx VnIB at various nAChR subtypes.

The antagonist properties of VnIB were determined at nAChRs expressed in Xenopus laevis oocytes by two-electrode voltage clamp (TEVC) electrophysiology as described in Materials and methods, section 2.3. Data is given as IC50 values and Hill slopes (nH) (with 95% confidence intervals in parentheses) and were obtained from recordings on at least three individual oocytes. r, rat; h, human; ND, not determined.

nAChR IC50 (nM) nH
rα6β4 12 (9.9–15) 1.2 (0.95–1.5)
rα6/α3β4 18 (16–20) 1.1 (0.97–1.2)
rα3β4 320 (250–390) 1.2 (0.96–1.5)
rα6/α3β2β3 4000 (2500–6900) 0.53 (0.42–0.66)
hα1β1δε >10,000 ND
rα2β2 >10,000 ND
rα2β4 >10,000 ND
rα3β2 >10,000 ND
rα4β2 >10,000 ND
rα4β4 >10,000 ND
rα7 >10,000 ND
rα9α10 >10,000 ND

hα6/α3β4 5.3 (4.1–6.9) 1.1 (0.84–1.5)
hα3β4 >10,000 ND
hα6/α3β2β3 >10,000 ND
hα4β2 >10,000 ND